Cavitat Generation 4 (Ultrasonograph)

Patent #  6030221  FDA Ref # K011147

Cavitat Medical Technologies, Inc. is in the business of developing, Manufacturing and marketing new and innovative technologies to detect and precisely image porosity of the bone. As an aid to medical professionals, when used adjunctive to a radiograph, in diagnosing the debilitating effects of Bone Marrow Edema Syndrome, Neuralgia Inducing Cavitational Osteonecrosis (NICO), Osteomyelitis, and Periodontal Pockets of the Buccal Bone. The CAVITAT Generation 4 Precisely images and identifies cavitational porosity in the jawbone. The worlds leading technology in bone sonography imaging systems.

Welcome to

CAVITAT MEDICAL TECHNOLOGIES, Inc

The new Generation 4 software and mouthpiece produces this screen image, allowing one full quadrant to be displayed

The CAVITAT (Ultrasonograph) Generation 4 was cleared for commercial distribution by the Food And  Drug Administration (FDA) on  February 15, 2002.  Reference Number K011147

The American Medical Association has assigned a CPT coding number 76977 for CAVITAT scans and interpretations.